Atrial Fibrillation Clinical Trials in Shanghai
3 recruitingShanghai, China
Showing 1–3 of 3 trials
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
PulseSelect™ PFA Global Registry
Atrial Fibrillation
Medtronic Cardiac Ablation Solutions1,950 enrolled28 locationsNCT06393920
Recruiting
Not Applicable
Optimized Ablation of the Posterior Wall in Persistent Atrial Fibrillation
Persistent Atrial Fibrillation
Shanghai Chest Hospital384 enrolled1 locationNCT07122336